The IQGAP1 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population generated from the NCI-H1975 human lung adenocarcinoma cell line, featuring targeted disruption of the IQGAP1 gene. This loss-of-function model enables investigation of the scaffold protein IQGAP1 in a non?small cell lung cancer (NSCLC) background. The polyclonal format preserves natural genetic heterogeneity while eliminating IQGAP1 expression across the culture, providing a robust system for functional studies without the selection pressure of single?cell cloning.
The parental NCI-H1975 cell line was derived from a female non?smoker with lung adenocarcinoma carrying the oncogenic EGFR L858R mutation in the kinase domain. This cell line is a well?established model of EGFR?driven NSCLC, characterized by constitutive activation of MAPK/ERK and PI3K/AKT signaling cascades, and is frequently employed to examine EGFR?dependent proliferation, survival, metastasis, and therapeutic resistance. The NCI-H1975 background is thus ideal for dissecting signaling networks that interact with or bypass mutant EGFR.
IQGAP1 is a multi?domain scaffold that integrates signals to coordinate actin dynamics, adhesion, and transcription. It binds calmodulin, F?actin, Rac1, and Cdc42, regulating lamellipodia and cytoskeletal remodeling. IQGAP1 also interacts with ???catenin, APC, and E?cadherin, modulating Wnt/???catenin activity and junction integrity. Through EGFR?CRas?CMAPK, it facilitates ERK phosphorylation, linking receptors to gene expression. This positions IQGAP1 as a node controlling proliferation and motility.
In the context of EGFR?mutant lung adenocarcinoma, IQGAP1 is thought to promote tumor progression by sustaining both ERK and Wnt/???catenin signaling downstream of oncogenic EGFR. Disruption of IQGAP1 in NCI-H1975 cells is expected to impair actin?dependent processes such as wound?healing migration and transwell invasion, attenuate ERK activation, and destabilize ???catenin?mediated transcription. Consequently, this knockout model permits detailed dissection of IQGAP1?dependent mechanisms driving metastasis, proliferation, and resistance to EGFR?targeted agents, illuminating the scaffold??s role in malignant signaling networks.
This polyclonal knockout population is suitable for a broad array of functional and biochemical analyses. Proliferation can be measured via MTT or CellTiter?Glo assays; motility and invasion can be assessed using wound?healing scratch assays and transwell chambers, respectively. Western blotting and co?immunoprecipitation can detect changes in phospho?ERK, phospho????catenin, and IQGAP1?interacting partners. Immunofluorescence microscopy enables visualization of actin stress fibers and E?cadherin localization. Drug sensitivity testing with EGFR inhibitors (e.g., osimertinib, erlotinib) can probe IQGAP1??s contribution to therapeutic response. For additional information, please contact Ascent Research.
